Difference between revisions 3680045 and 3680050 on simplewiki⏎ ⏎ {{Infobox company | name = Katan Technologies | logo = [[File:Katan Technologies Logo.jpg|180px]] | | caption = ''Technologies for Healthy Environments'' | type = | traded_as = | genre = <!-- Only used with media and publishing companies --> | fate = | predecessor = | successor = | foundation = 2011 | founder = | defunct = <!-- {{End date|YYYY|MM|DD}} --> | location_city = [[Colombia]], [[Mauritius]], [[Panama]], [[Singapore]], [[United States]]| | location_country = | locations = | area_served = | key_people = | industry = | products = [[Chemicals]], [[Hygiene]], [[Sanitization]]| | services = | revenue = | operating_income = | net_income = | aum = <!-- Only used with financial services companies --> | assets = | equity = | owner = | num_employees = | parent = | divisions = | subsid = | homepage = {{URL|katantech.com}} | footnotes = | intl = }} '''Katan Technologies''' (often referred to as '''KatanTech''') is a global company that specializes in the research, development and marketing of antimicrobial technologies, with focus on eco-responsibility and the ability of its products to prevent microbial mutation or the creation of super-microbes. The company operates in five countries, and its brands are sold and used globally. The company cites durable protection without the use of [[triclosan]]<ref> {{citation | contribution = Reregistration Eligibility Decision for Trimethoxysilyl Quaterny Ammonium Chloride Compounds. | title = Reregistration for Elligibility Decision (RED) Trimethoxysilyl Quaternary Ammonium Chloride Compounds | publisher = United States Environmental Protection Agency | date = Sept 2007| id = | accessdate = 2012-06-20}}</ref> as a key user benefit. ==History== The company was founded in 2011 after several years of R&D and business development. The company is headquartered in Mauritius with subsidiaries in Colombia, Panama, Singapore and the U.S.A.<ref> {{cite journal | title = Solving the Hospital Acquired Infection Crisis and Microbial Cross-Contamination Problems in Health Care and Related Applications. | journal = Portofino and Associates White Paper | first = Tatjana | last = Hutnyak | pages = 4-5| id = | accessdate = 2012-06-17}}</ref> The company plans to expand operations to Australia, Central America, Ecuador and New Zealand in 2012.<ref> {{cite journal | title = Solving the Hospital Acquired Infection Crisis and Microbial Cross-Contamination Problems in Health Care and Related Applications. | journal = Portofino and Associates White Paper | first = Tatjana | last = Hutnyak | pages = 4-5| id = | accessdate = 2012-06-17}}</ref> ==Products== S.P.A.D.A. (Self-Aligning, Polymeric, Antimicrobial, Durable Array) serves as one of the core antimicrobial technologies of Katan Technologies’ products. S.P.A.D.A. consists of positively charged polymers that molecularly bond to various surfaces.<ref> {{cite web | url = http://www.katantech.com/kt/ | title = Katan Technologies | accessdate = 2012-06-13 | date = 2012}}</ref> The products are separated into brands that identify the markets into which the S.P.A.D.A. and other Katan technologies are applied. :* Biospada- All-surface antimicrobial protector :* Biospada PLUS- All-surface antimicrobial disinfectant, protector and cleaner :* Verdespada Agro- Antimicrobials for agriculture :* Verdespada Pecuario (for Animals)- Antimicrobials for industrial dairy, aviculture, rabbit breeding and other breeding facilities :* Aplaus- Retail products including hand sanitizers :* Denki- Antimicrobials for high temperature manufacturing processes :* Finfire- A water-based, flame-retardant agent ==Competitors== * [[Clorox]] * [[Purell]] * [[Dettol]] * [[Pine-Sol]] ==References== <div class='references-small'> <references/> </div> "Katan Technologies." Katan Technologies. ICBits, 2012. Web. 14 June 2012. <http://www.katantech.com/kt/>.<ref> {{cite web | url = http://www.katantech.com/kt/ | title = Katan Technologies | accessdate = 2012-06-13 | date = 2012}}</ref> Hutnyak, Tatjana. "Solving the Hospital Acquired Infection Crisis and Microbial Cross-Contamination Problems in Health Care and Related Applications."Portofino and Associates White Paper (Jan. 2010): 4-5. Print. <ref> {{cite journal | title = Solving the Hospital Acquired Infection Crisis and Microbial Cross-Contamination Problems in Health Care and Related Applications. | journal = Portofino and Associates White Paper | first = Tatjana | last = Hutnyak | pages = 4-5| id = | accessdate = 2012-06-17}}</ref> "Reregistration Eligibility Decision for Trimethoxysilyl Quaterny Ammonium Chloride Compounds." National Service Center for Environmental Publications. EPA United States Environmental Protection Agency, Sept. 2007. Web. 20 June 2012. <http://nepis.epa.gov/Exe/ZyNET.exe/P1006LYJ.TXT?ZyActionD=ZyDocument>.<ref> {{citation | contribution = Reregistration Eligibility Decision for Trimethoxysilyl Quaterny Ammonium Chloride Compounds. | title = Reregistration for Elligibility Decision (RED) Trimethoxysilyl Quaternary Ammonium Chloride Compounds | publisher = United States Environmental Protection Agency | date = Sept 2007| id = | accessdate = 2012-06-20}}</ref> ==External Links== Official Site: http://www.katantech.com/kt/index.cfm All content in the above text box is licensed under the Creative Commons Attribution-ShareAlike license Version 4 and was originally sourced from https://simple.wikipedia.org/w/index.php?diff=prev&oldid=3680050.
![]() ![]() This site is not affiliated with or endorsed in any way by the Wikimedia Foundation or any of its affiliates. In fact, we fucking despise them.
|